Folic Acid

# Folic acid ## Overview - **Classification**: Water-soluble B vitamin (B9), Hematopoietic agent. - **Mechanism**: Essential coenzyme for DNA synthesis, repair, and methylation. Crucial for red blood cell maturation. ## Primary Indications 1. **Folic acid deficiency** - Treatment and prevention, particularly megaloblastic anemia. 2. **Neural tube defect (NTD) prevention** - In women of childbearing potential before and during pregnancy. 3. **Methotrexate toxicity reduction** - As 'rescue' therapy or to mitigate side effects from chronic low-dose MTX. ## Adult Dosing ### Standard Dosing **Folic Acid Deficiency / Megaloblastic Anemia** - **Dose**: **1 mg** - **Frequency**: Once daily - **Route**: Oral (PO) - **Duration**: Often several months or lifelong for malabsorption syndromes. **Neural Tube Defect (NTD) Prevention (Low Risk)** - **Dose**: **0.4 mg** - **Frequency**: Once daily - **Route**: Oral (PO) - **Special Consideration**: Begin at least 1 month prior to conception; continue through first trimester. **NTD Prevention (High Risk - e.g., prior NTD, diabetes, anti-epileptics)** - **Dose**: **4 mg** - **Frequency**: Once daily - **Route**: Oral (PO) - **Special Consideration**: Begin at least 1 month prior to conception; continue through first trimester. **Methotrexate (MTX) Toxicity Reduction (Prophylaxis)** - **Dose**: **1 mg** to **5 mg** - **Frequency**: Once daily - **Route**: Oral (PO) - **Special Consideration**: Typically on non-MTX dosing days. Higher doses for higher MTX regimens. ### Dose Adjustments - **Renal Impairment**: No specific dose adjustment required. - **Hepatic Impairment**: No specific dose adjustment required. - **Elderly Patients**: No specific dose adjustment; standard adult doses apply. ## Pediatric Dosing ### Neonates (0-28 days) - **For deficiency/prophylaxis in high-risk infants (e.g., prematurity, malabsorption)** - **Dose**: **50-100 mcg (0.05-0.1 mg)** - **Frequency**: Once daily - **Route**: Oral (PO) or Intravenous (IV) - **Maximum**: **100 mcg** daily - **Special Notes**: Consider in premature infants or those on long-term TPN. ### Infants (1-12 months) - **Folic acid deficiency/Megaloblastic Anemia** - **Dose**: **0.1 mg** to **0.5 mg** - **Frequency**: Once daily - **Route**: Oral (PO) - **Maximum**: **0.5 mg** daily ### Children (1-12 years) - **Folic acid deficiency/Megaloblastic Anemia** - **Dose**: **0.1 mg** to **1 mg** - **Frequency**: Once daily - **Route**: Oral (PO) - **Maximum**: **1 mg** daily ### Adolescents (13-18 years) - **Dose**: Approach adult dosing, typically **0.4 mg** (prophylaxis) to **1 mg** (deficiency). - **Maximum**: **1 mg** daily (unless specific high-dose indication like MTX rescue). ## Safety Information ### Contraindications - **Absolute**: Untreated pernicious anemia (masking B12 deficiency risks neurological damage). - **Absolute**: Known hypersensitivity to folic acid. ### Common Adverse Effects - **Very Common (>10%)**: Folic acid is generally very well-tolerated. - **Common (1-10%)**: Nausea, loss of appetite, bloating, bitter taste (oral). - **Serious but Rare**: Allergic reactions (rash, pruritus, bronchospasm, erythema). ### Key Drug Interactions - **Methotrexate**: Folic acid can reduce MTX efficacy if given simultaneously; separate dosing times. - **Antiepileptics (e.g., phenytoin, phenobarbital, primidone)**: Folic acid can decrease plasma levels; monitor antiepileptic levels. - **Sulfasalazine**: May inhibit intestinal absorption of folic acid; higher folic acid doses may be needed. - **Chloramphenicol**: May antagonize the hematopoietic response to folic acid supplementation. ## Monitoring & Follow-up - **Before Treatment**: Check **Vitamin B12 levels** to rule out pernicious anemia if megaloblastic anemia is present. - **During Treatment**: Monitor **CBC** (hemoglobin, MCV) to assess response if treating anemia. - **Clinical Signs**: Watch for resolution of symptoms like fatigue, pallor, and improved energy. ## Clinical Pearls - 💡 **Tip 1**: **ALWAYS rule out Vitamin B12 deficiency** before starting folic acid for megaloblastic anemia. - 💡 **Tip 2**: For NTD prevention, initiate folic acid **at least one month before conception** for optimal benefit. - 💡 **Tip 3**: Folic acid is often included in **prenatal vitamins** (typically **0.8-1 mg**). - 💡 **Tip 4**: Advise patients to take folic acid consistently; compliance is key, especially for prevention. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.